Tomasz Sablinski MD, PhD

Dr Tomasz Sablinski is currently Head of Development and a Managing Director of Celtic Therapeutics Development. He founded TLS in 2010 stimulated by the opportunities to introduce a new model of drug development afforded by modern computer sciences, technology, and new communication and knowledge generation patterns. He has over thirty years of experience in healthcare. This includes fifteen years of pharmaceutical development in a major pharmaceutical company, a CRO, and consulting for small biotechnology companies. His experience in these roles includes time in the United States, Europe and Japan. In the 1990s he was a member of Harvard Medical School (Brigham and Women’s and Massachusetts General hospitals) teams conducting pioneering work in developing biologic immunosuppressive regimens, induction of transplantation tolerance and xenotransplantation. In parallel, and prior to this, he practiced as a surgeon specializing in renal transplantation and general surgery in his native Poland and in Boston. Transparency Life Sciences’ origins lie in a strong belief that the current system of drug development must be completely changed, and in a passion for development of medications at a fraction of current cost. He received his MD and PhD from the Academy of Medicine in Warsaw.